elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55436511-92487DF6-37A6-45DD-A448-4D9C30065485
Q55436511-92487DF6-37A6-45DD-A448-4D9C30065485
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55436511-92487DF6-37A6-45DD-A448-4D9C30065485
A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulin.
P2860
Q55436511-92487DF6-37A6-45DD-A448-4D9C30065485
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55436511-92487DF6-37A6-45DD-A448-4D9C30065485
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d88b32e94e5aba8bd76222ffd5df82c479a18ae5
P2860
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.